• 3-5 Impasse Reille 75014 Paris France
  • info@depixus.com

Depixus will be participating in the Protein-RNA Interactions Keystone Symposia from 29 January to 1 February 2023.

This meeting addresses growing excitement from both the basic and translational life sciences community in imagining protein-RNA interactions as a treasure trove of new biology and drug targets. It will provide a forum to assemble multi-disciplinary leaders in various themes in the RNA community to cross-fertilize emerging ideas in fundamental protein-RNA science, introduce a diversity of new-comers to the newest methods and results in the field and introduce and identify new targets and modalities for therapeutic opportunities.

We look forward to joining you there!

AGBT 2022

Dr Gordon Hamilton, CEO, and Dr Nigel Skinner, Head of Product Management & Marketing, will be participating in the AGBT General Meeting, from 6 – 9 February, in Hollywood, Florida.

This is the pre-eminent genome science and technology conference for top global researchers, leaders and innovators.

We look forward to seeing you there!

Depixus will be participating in the CHI Drug Discovery Conference section on ‘RNA-Targeting Small Molecule Drugs’, from 11 – 12 April, in San Diego.

Drug Discovery Chemistry is a dynamic conference for medicinal and biophysical chemists working in pharma, biotech, and academia, focused on discovery and optimization challenges of small molecule drug candidates.

We look forward to seeing you there!